Randox Release: Multi-Analyte Immunoassay Control with Assayed Values for 54 Analytes Including Vitamin D

Crumlin, UK , December 22, 2011 / B3C newswire / - As the demand for Vitamin D testing increases so does the demand for accurate and reliable test results. The Randox Acusera immunoassay premium plus control is designed to monitor the accuracy and precision of up to 54 analytes including 25-OH Vitamin D and 1-25(OH)2 Vitamin D. In addition to this instrument specific target values are provided for a wide range of fertility hormones, thyroid hormones, steroid hormones, kidney function tests, therapeutic drugs and tumour markers. The inclusion of routinely run tumour markers and parameters such as intact PTH allows you to simplify your quality control practices by dramatically reducing the number of controls used in your laboratory with the added benefit of cost and time savings.

Three levels of control are available covering the complete clinical range. In the level 1 control Ferritin, vitamin B12 and TSH are present at clinically significant levels further eliminating the need to purchase additional and often expensive low level controls.

With a shelf life of up to four years from the date of manufacture; our immunoassay premium plus control is suitable for long term QC monitoring and can significantly reduce the costs and problems associated with changing lot numbers.

Like all our immunoassay controls, our immunoassay premium plus control is manufactured from 100% human materials meaning it won’t interfere with antibody based tests or cause problems when changing batch of reagent.

As a true supplier of third party controls Randox products provide an unbiased, independent assessment of performance. Our unique value assignment process employs over 20,000 independent laboratories worldwide making our controls the most accurately assigned on the market. With 30 years experience in quality control; excellent choice, stability and most importantly performance is guaranteed.

Vitamin D can also be found in our RIQAS Immunoassay EQA programme. RIQAS (Randox International Quality Assessment Scheme) is the world’s largest global EQA scheme with more than 20,000 participants in over 100 countries worldwide. Our extensive immunoassay programme contains 54 analytes in total including Vitamin D however participants can choose to monitor a reduced number of analytes. Like our immunoassay controls all samples are 100% human in origin meaning they won’t interfere with antibody based tests.

About Randox

Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.

For more information contact us at marketing@randox.com

MORE ON THIS TOPIC